✦ LIBER ✦

Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients

✍ Scribed by P. Soulié; C. Garrino; M. A. Bensmaïne; M. Bekradda; E. Brain; M. Di Palma; A. Goupil; J. L. Misset; E. Cvitkovic

Book ID: 106124864
Publisher: Springer-Verlag
Year: 1999
Tongue: English
Weight: 94 KB
Volume: 125
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s004320050338

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of ifosfamide plus cisplatin-ba

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors

✍ Robert J. Motzer; Karen Cooper; Nancy L. Geller; Dean F. Bajorin; Ethan Dmitrovs 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

A prospective study of four cycles of etoposide with ifosfamide and cisplatin (VIP) chemotherapy was conducted in 42 germ cell tumor (GCT) patients who were refractory to cisplatin with etoposide/vinblastine-based therapy. Forty patients were evaluable for response. Ten patients (25%) had a complete

Irinotecan in patients with relapsed or

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

✍ Kollmannsberger, C; Rick, O; Klaproth, H; Kubin, T; Sayer, H G; Hentrich, M; Wel 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 76 KB

Reply: Irinotecan in patients with relap

Reply: Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

✍ Kollmannsberger, C; Bokemeyer, C 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 55 KB

Salvage chemotherapy with paclitaxel and

Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors

✍ Takumi Shiraishi; Terukazu Nakamura; Kazuya Mikami; Natsuki Takaha; Akihiro Kawa 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 236 KB

Combination therapy with docetaxel and l

Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study

✍ Jaime Feliu; Jose Luis Firvida; Javier Castro; Catherina Madroñal; Angeles Rodrí 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 280 KB

Phase II study of capecitabine and cispl

Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy

✍ Kang, H J; Chang, H M; Kim, T W; Ryu, M-H; Sohn, H J; Yook, J H; Oh, S T; Kim, B 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB